Today’s AI Top Pick: BILI

9/1/2026 · Turnaround screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured weekly model accuracy · BILI60%55 resolved forecasts · 90d window · verify →

View the live BILI price forecast →

Today's pick · TurnaroundBILIBUY NOW8.7 / 109/1/2026

Bilibili is the cleanest setup on the board today: multi-timeframe forecasts are unanimously bullish across 4h (+71.76% short / +75.99% mid / +65.22% long), 1d (+20.03% / +64.48% / +36.27%), and 1wk (+6.65% / +17.67% / +33.13%), with position_in_21bar_range_pct sitting at 0 on ALL three timeframes. This is the textbook 'not chasing' profile — the stock has been beaten (perfYear -30.52%, perfYtd -34.28%, 1wk dd -36.58% from range high) yet the model still assigns near_term_bullish = 1.0 and bullish_prob = 1.0. Every other high-conviction name here has at least one flaw: APP has a deeply negative weekly forecast (-29.52% long), NRG's weekly long is -36.95%, ORCL's 4h mid is -9.79%, and CLBT just had a CEO shift and guidance cut in August. Fundamentally BILI passed the screen with room to spare: fwdPe 12.51 (cheapest FCF-adjacent multiple among the near-term bullish names), peg 0.52, epsNextY +26.71%, salesYoY +10.34%, recom 1.29 (near strong buy), and targetUpsidePct +63.9%. Profitability is thin (profitMargin 4.87%, operMargin 4.44%) but improving, and the ADR structure explains the light instOwn (8.08%) — that's not a red flag. Critically, the news flow just turned. The Sep 1 Insider Monkey piece calls out that BILI's 'ad engine and margins outrun its slumping game unit,' and the Q2 2026 earnings call (Aug 27-31) was flagged for 'record margins and AI-driven growth.' That's a fresh, materially positive catalyst landing exactly when the tape says the stock has stopped bleeding. Contrast this with ORCL (Steve Eisman OpenAI-recession warning) and CLBT (guidance cut) — both undercut by news. Waiting doesn't help here. Position in range is already 0 across timeframes, meaning we are AT the reset. Any bounce off this floor front-loads the 4h +71% and 1d +64% mid-horizon moves. The asymmetry — small downside vs. record-margins narrative + $16 vs analyst target implying $26+ — is what makes this a buy today, not a pullback wait.

BILI forecast chart
Entry zone
$15.70 – $16.20 (starter at market $15.95, add on any dip toward $15.40 which is the 21-bar low pivot)
Stop loss
$14.20 (below the 1wk dd zone; ~11% risk — invalidates the reversal setup)
First target
$19.20 (+20%, aligns with 1d fc_short +20.03% and clears the 4h range midpoint)
Longer target
$26.00 (+63%, matches analyst targetUpsidePct of 63.9% and the 4h/1d mid-horizon forecasts of +64–76%)
Risks
  • China ADR regulatory/geopolitical risk — instOwn only 8.08% means thin US institutional support if sentiment sours
  • 1wk recent_21bar_pct is -36.58% — knife-catching risk if the reversal isn't real; needs to hold $15.40
  • Gaming segment is 'slumping' per Sep 1 headline — if ad monetization slows, the margin story breaks
  • shortFloat 6.46% is moderate but not a squeeze catalyst; no forced short-cover tailwind
  • salesYoY only +10.34% — weakest topline growth among the top-forecast names (vs APP +28.5%, ALNY +95%)
Honorable mentions
PFSIAll-positive forecasts across 4h (+65.9/+72.97/+62.36), 1d (+7.54/+42.45/+30.92), and 1wk (+1.77/+7.58/+14.57), position 0/0/0 across timeframes, fwdPe 6.69 and peg 0.53 are the cheapest in the pool. Held back by recom 2.0 (weakest analyst support) and rate/housing cycle sensitivity.
ALNYExplosive 4h forecast (+57.89/+69.66) plus fresh Oppenheimer upgrade on nucresiran data and salesYoY +95.14%. peg 0.31 is best-in-class. Ranks behind BILI only because 1d is at 76% of range (chase risk) and weekly forecast is muted (+6/+7%).
Full ranking (15)
#SymbolVerdictScoreRead
1BILIBUY NOW8.7Unanimous bullish forecasts across 4h/1d/1wk, position 0/0/0 in range, fresh record-margin Q2 catalyst — pristine reversal setup.
2PFSIBUY NOW8.0All-positive multi-TF forecasts, cheapest fwdPe 6.69 in the pool, sitting at 0 range position with +42% 1d mid forecast.
3ALNYBUY NOW7.8peg 0.31, salesYoY +95%, +69% 4h mid forecast, plus fresh Oppenheimer positive data note on nucresiran.
4ACMBUY NOW7.4Clean all-positive forecasts, epsNextY +60%, fresh NZ contract win, position ~5–40% of range (not chasing).
5SRADBUY NOW7.0+58% 4h and +58% 1d mid forecasts, Polymarket/Euroleague deals, but pe 206 and thin profitMargin 1.23% cap conviction.
6BIRKBUY NOW6.8Rare 4-TF alignment (1h/4h/1d/1wk all positive), profitMargin 14.8%, recent 'affordable growth' notes; smaller forecast magnitude.
7APPBUY PULLBACK6.3Huge 4h/1d bounce forecasts but 1wk long is -29.52% — near-term rip, longer-term caution.
8NRGBUY PULLBACK6.0Strong 1d (+38.5% mid) but 1wk long is -36.95%; wait for confirmation the weekly trend flips.
9CALXBUY PULLBACK5.9Great 4h forecast (+44%) but already 86% of 4h range — chased; better on dip to $36.
10LIFBUY PULLBACK5.6peg 12.8 is stretched, 1d dd -34.9%, weekly forecast negative; wait for stabilization.
11TMUSWAIT5.5Modest forecasts, 1d already 80% of range, SpaceX competitive threat headline — no urgency.
12ORCLWAIT5.3Mixed forecasts (4h mid -9.79%, 1wk long -6.37%), OpenAI-recession warning headline undercuts thesis.
13FICOWAIT5.0Weekly forecast negative across all horizons (-6.6/-12.8/-10.3), already 78% of 1d range — chasing.
14SEWAIT4.5bullish_prob only 0.4, near_term 0.2, 1d forecasts flat-to-negative — thesis fading.
15CLBTAVOID4.0CEO shift AND guidance cut just landed (Aug 21) — broken thesis regardless of forecasts.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.